Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples